#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vaginal cancer Leukodystrophy Skin cancer Transplant rejection Ocular myasthenia Retinitis pigmentosa Thrombotic microangiopathy Brain abscess Acquired haemophilia Microscopic polyangiitis Lennox-Gastaut syndrome Multiple system atrophy Anaplastic thyroid cancer Henoch-Schonlein purpura Autoimmune myositis More trials…

    Learn about Rare Diseases

    MELAS syndrome Wiskott-Aldrich syndrome – Life with Disease Undifferentiated sarcoma – Trials in Disease Mast cell activation syndrome – Trials in Disease Nodal marginal zone B-cell lymphoma – Diagnostics Hereditary optic atrophy – Basic Information Chondrosarcoma Angiosarcoma non-metastatic – Life with Disease Familial amyotrophic lateral sclerosis – Trials in Disease Toxic epidermal necrolysis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    POTASSIUM CLAVULANATE Octreotide Hydrochloride Travoprost Amifostine Thiol Upacicalcet Sodium Hydrate PRILOCAINE HYDROCHLORIDE IDROXIOLEIC ACID Apadamtase Alfa Gsk3858279 Tobramycin Danazol Ondansetron Hydrochloride Evx-01 Cloxacillin Sodium Crizanlizumab Mps-200 RO7268489 Gskvx000000017033 Diltiazem Hydrochloride Permethrin More therapies…

    Learn about Your Condition

    Paraganglion neoplasm Osteomyelitis Allergic respiratory disease Pleural mesothelioma malignant Migraine Pleomorphic leiomyosarcoma Vulval cancer Haemorrhagic stroke Lymphocytic lymphoma Partial seizures Psychogenic seizure Raynaud's phenomenon Toxic nodular goitre Immunodeficiency congenital Infantile spasms More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hypothyroidism

  • Effect of levothyroxine on kidney function in patients at risk of hypothyroidism after partial thyroid surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypothyroidism
    • Chronic kidney disease
    Investigated Drugs:
    • Levothyroxine
    Denmark

  • Study on Levothyroxine and Liothyronine for Patients with Autoimmune Hypothyroidism and Persistent Tiredness

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hypothyroidism
    The Netherlands

  • Study on Levothyroxine and Sildenafil for Improving Erectile Function in Patients with Subclinical Hypothyroidism and Erectile Dysfunction

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypothyroidism
    Investigated Drugs:
    • Levothyroxine
    • Sildenafil Citrate
    Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!